Yearly Publication Trends - antidepressants

Year	Publication Count
2025	3
2024	1363
2023	2370
2022	1459
2021	1243
2020	1340
2019	751
2018	651
2017	487
2016	762
2015	437

Relevant Publications

[Resolvin E1 as a potential lead for the treatment of depression].

Issue Release: 2024

[Underlying mechanisms for psychotropic effects of delta opioid receptor agonists].

Issue Release: 2024

[Strategy for the development of small-molecule antidepressant targeting PAC1 receptor].

Issue Release: 2024

Prenatal exposure to vortioxetine and vilazodone: Impact on depressive- and anxiety-like behavioral manifestations in young rat offspring.

Issue Release: 2024

The Impact of Training in Multimodal Communication Skills on Psychotropic Medication Use in Dementia Care.

Issue Release: 2024

Co-occurring psychiatric disorders in young people with eating disorders: An multi-state and real-time analysis of real-world administrative data.

Issue Release: 2024

GPR56: A potential therapeutic target for neurological and psychiatric disorders.

Issue Release: 2024

User-Centered Design of a Preference-Driven Patient Activation Tool for Optimizing Depression Treatment in Integrated Primary Care Settings (The Transform DepCare Study).

Issue Release: 2024

Psychotropic medications and mortality from cardiovascular disease and suicide for individuals with depression in Taiwan.

Issue Release: 2024

Discontinuation symptoms of antidepressants.

Issue Release: 2024

Characteristics of drug overdose suicide attempts presenting to the psychiatric emergency department of Beijing Anding Hospital.

Issue Release: 2024

Efficacy and safety of Chinese patent medicines combined with antidepressants for treatment of depression in adults: A multiple-treatment meta-analysis.

Issue Release: 2024

Effect of add-on transcranial alternating current stimulation (tACS) in major depressive disorder: a randomized controlled trial.

Issue Release: 2024

Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review.

Issue Release: 2024

Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN.

Issue Release: 2024

Epigenetic Aging in Major Depressive Disorder: Clocks, Mechanisms and Therapeutic Perspectives.

Issue Release: 2024

Chronic Pain for Rheumatological Disorders: Pathophysiology, Therapeutics and Evidence.

Issue Release: 2024

The dual roles of serotonin in antitumor immunity.

Issue Release: 2024

A Longitudinal Study of the Use and Effects of Fall-Risk-Increasing Drugs in Residential Aged Care.

Issue Release: 2024

Drugs, Delirium, and Trauma: Substance Use and Incidence of Delirium After Traumatic Brain Injury.

Issue Release: 2024

What Role Does Technology Play?

What Role Does Cellular Stress Play in Disease?

How Can Technology Aid in Management?

Why is Generic Competition Important?

What Are the Challenges of Clinical Trials?

What Strategies do Brand-Name Companies Use to Delay Generic Entry?

What Should Be Included in Patient Education Materials?

Why is Geriatric Care Important?

Why is Transitional Care Important in Pharma?

What are the Phases of Clinical Trials?

Partnered Content Networks

Relevant Topics